Loading...
Women who undergo breast-conserving surgery (BCS) typically receive adjuvant radiation therapy (RT) in short order. Delaying RT to the breast after BCS is hypothesized to give microscopic residual disease a chance to disseminate, which then heightens risk for local and distant recurrence and diminished overall survival (OS). Nevertheless, patients are often undecided about RT or opposed to it. Unfortunately, assessments of the association between clinical outcomes and BCS-to-RT intervals have yielded disparate results, often because studies have been limited by a paucity of patients who initiate RT >12 weeks after BCS.
To further investigate the impact of BCS-to-RT intervals on survival, researchers analyzed prospective data on 6428 women in…